A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants
This research study is looking at new ways to deliver a medicine, using different versions called KarX and KarT prototypes. The main goal is to compare how these new versions work in the body against the existing KarXT and KarX-EC medicines after someone takes just one dose. They also want to understand if eating food changes how the body handles these new medicine versions when taken over several days. This type of study helps scientists learn how a drug is absorbed, distributed, processed, and removed by the body, which is crucial for developing safe and effective treatments. It involves healthy adult volunteers and is an early stage (Phase 1) of drug development.
At a glance
What is this study about?
Imagine a medicine you take for an illness. When you swallow it, your body has to absorb it and use it. This study is like a test drive for new versions of a medicine. Researchers are looking at different ways to package or formulate a medicine called KarXT and KarX-EC. Think of it like comparing different types of outer coatings for a pill – some might dissolve faster, some might be better with food.
The main idea is to see how these new versions, or "prototypes," behave in healthy adults. They want to compare them to the current versions of the medicine. The study will first give a single dose of the new versions to see how they are absorbed and processed by the body. This helps understand their basic behaviour.
After that, for some chosen new versions, the study will explore if eating food changes anything when people take multiple doses. Sometimes food can affect how much medicine gets into your system or how quickly. This early research is very important for making sure future medicines are safe, work well, and are easy for patients to take.
Key takeaways
- Researchers are testing new versions of a medicine called KarXT and KarX-EC.
- The study includes healthy adult volunteers.
- It aims to understand how the body processes these new medicines after single and multiple doses.
- They will also check if food affects how the medicine works.
- This is an early-stage study to gather important information for future drug development.
Who may be eligible?
To join this study, volunteers need to be healthy adults. You must be between 18 and 55 years old.
Your Body Mass Index (BMI), which is a measure relating your weight and height, must be between 18.0 and 32.0. This range helps ensure participants are within a healthy weight category for the study, as extreme weights can sometimes affect how medicines work in the body.
There might be other specific health checks or conditions that the study doctors will go through with you. These are put in place to ensure your safety and that the study results are clear and accurate.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 18 and 55 years old?
- Do you consider yourself a healthy adult?
- Is your Body Mass Index (BMI) between 18.0 and 32.0?
- Are you able to commit to the study visits and requirements?
What does participation involve?
If you decide to take part, you'll be given either the new investigational medicine (a capsule containing Xanomeline and Trospium Chloride, or a Xanomeline Enteric Capsule, or just Trospium Chloride) or the existing reference versions, following a specific schedule. This will involve taking single doses initially, and for some parts of the study, multiple doses.
Throughout the study, you'll have regular hospital visits for assessments. This will likely include blood tests, urine samples, and possibly other health checks to see how your body is responding to the medicine and if there are any changes. For the part of the study looking at the effect of food, you will be given the medicine both with and without food, typically under controlled conditions.
The total duration of your involvement, including all visits and follow-ups, will be clearly explained to you by the study team. You'll be closely monitored by doctors and nurses to ensure your safety and comfort at all times.
Potential risks and benefits
Locations (1)
- Quotient SciencesVerified postcodeNottingham, United Kingdom· Recruiting
Common questions
What kind of medicine are they testing?
They are testing new versions of a medicine called KarXT and KarX-EC, along with components like Xanomeline and Trospium Chloride. These are being compared to existing forms of the medicine.
Why is it important to test medicines in healthy volunteers?
Testing in healthy volunteers helps researchers understand how the medicine works in the body under normal conditions, before it's given to people with a specific illness. This is a crucial early step in drug development.
What does 'single doses' and 'multiple doses' mean?
Single doses mean you take the medicine just once. Multiple doses mean you take it more than once, typically over several days, to see how the body handles it over a longer period.
What does 'effect of food' mean in this study?
It means the researchers want to see if eating food at the same time as taking the medicine changes how much of the medicine gets into your body or how quickly it works.
Will I know if I'm getting the new version or the old one?
The study team will explain how participants are assigned to different groups, including whether that information is kept secret (blinded) to ensure fair results.
How to find out more
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.